The upcoming clinical trial conferences will host talks on supply chain resilience, AI’s growing role and forging industry ...
GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia ...
Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance Treg function, releases the following letter to ...
Merck reported that a new formulation of Keytruda appears to deliver similar blood levels of the drug when given as a shot as ...
Discover six bispecific antibody companies developing a two-in-one approach to delivering targeted therapeutics to patients.
Zacks Small Cap Research on MSN53m
RVPH: Year-End OLE UpdateRVPH READ THE FULL RVPH RESEARCH REPORT Operational and Financial Results On November 14th, 2024, Reviva Pharmaceutical ...
Indianapolis-based OrthoIndy treated the first patients with Theradaptive's OsteoAdapt SP spinal fusion implant as part of an ongoing clinical trial. The Phase I/II Oasis trial is asssing the safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback